Publication | Closed Access
Tamoxifen resistance in breast cancer cells is accompanied by an enhanced motile and invasive phenotype: Inhibition by gefitinib (`Iressa', ZD1839)
111
Citations
38
References
2004
Year
Breast OncologyTamoxifen ResistanceMedicineBreast Cancer CellsPharmacologyCancer GrowthInvasive PhenotypeBreast CancerCancer BiologyCancer TreatmentOncologyCell BiologyTumor BiologyEndocrine-related Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1